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Context: Viral/bacterial infection is proposed as a trigger for the autoimmune thyroid diseases
(AITD): Graves’ disease (GD) and Hashimoto’s thyroiditis (HT). Previous studies in European Cau-
casian AITD subjects found higher birth rates in the autumn/winter, suggesting those born in the
autumn/winter experience increased viral/bacterial exposure after birth, impacting upon immune
system development and predisposing to AITD later in life.
Objective: Month of birth effects were investigated in three independent European Caucasian
AITD datasets.
Design: Variation in GD and HT onset was compared across months and seasons, with fluctuations
across all 12 months analyzed using a Walter-Elwood test.
Setting: The study was conducted at a research laboratory.
Patients:National UKCaucasianAITDCase Control Collection (2746GDand 502HT comparedwith
1 423 716 UK births), National UK Caucasian GD Family Collection (239 GD and 227 unaffected
siblings), and OXAGEN AITD Caucasian Family Collection (885 GD, 717 HT, and 794 unaffected
siblings of European Caucasian decent).
Main Outcome Measures: Case-control and family-based association studies were measured.
Results:No consistentmonth of birth effects were detected in GD females ormales across all three
collections. InHT females from theOXAGENAITDCaucasian Family Collection, slightly higher birth
rates were detected in autumn (Walter’s test statistic 7.47, P .024) however, this was not seen
in the HT females from the case-control cohort.
Conclusion: Our results suggest in UK/Northern European Caucasian GD subjects, month of birth
doesnot impactonAITDdevelopment.Although somemonthofbirtheffects forHT females inone
collection cannotbeexcluded, only furtherwork in larger EuropeanCaucasianAITDcollections can
confirm these effects. (J Clin Endocrinol Metab 99: E1459–E1465, 2014)
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Viral/bacterial infection is proposed as a key environ-mental trigger for the common autoimmune thyroid
diseases (AITD), Graves’ disease (GD) and Hashimoto’s
thyroiditis (HT) (1, 2). Severalmechanismshave beenpro-
posed to explain viral/bacterial triggering of AITD, in-
cluding molecular mimicry and viruses/bacteria acting as
superantigens (2). Interestingly, Enterovirus infection
during gestation and after birth is proposed to play a role
in type 1 diabetes (T1D) onset and other autoimmune
diseases (3–5), suggesting viral/bacterial exposure during
gestation or early in life could alter immune system devel-
opment, predisposing to autoimmune disease later in life.
Further support for this hypothesis comes from variation
in seasonality of birth rates observed inmanyautoimmune
conditions comparedwith the general population (6, 7). In
AITD, Krassas et al (8) investigated month of birth in 359
Greek GD and 664 HT patients compared with 37 119
general population births. Greek GD female birth rates
peaked in the spring/autumn, GDmale birth rates peaked
in the winter, HT female birth rates peaked in the winter,
andHTmale birth rates peaked in the winter/summer (8),
which varied from the general Greek population in which
female and male birth rates peaked in the summer. This
suggests birth rates of AITD patients are increased in the
autumn/winter months when viral/bacterial load is high-
est. Although several studies have investigated month of
birth effects in T1D, multiple sclerosis, and celiac disease
(9–11), only limited work has been performed to investi-
gate a possible role formonth of birth effects inAITD.The
aim of this study was to investigate whether alterations in
month of birthwas impacting uponAITDonset inUKand
European Caucasian populations by looking at seasonal-
ity of birth rates in a large AITD case-control collection
and two independent Caucasian family collections.
Materials and Methods
Subjects
Month of birth effects were analyzed within theNational UK
Caucasian AITD Case Control Collection (2281 GD females,
465 GD males, 433 HT females, and 69 HT males) compared
against 1 423 716UKbirths from1956 through1957 (12). Sam-
ples were recruited from centers in Birmingham, Bournemouth,
Cambridge, Cardiff, Exeter, Leeds, Sheffield, and Newcastle,
United Kingdom (see Supplemental Methods for further infor-
mation on recruitment criteria). Month of birth was also exam-
ined within two family collections. The National UK Caucasian
GD Family Collection (206 GD females, 33 GD males, 132 un-
affected female siblings, and 95 unaffected male siblings) were
recruited from the same centers as the National UK Caucasian
AITDCaseControlCollection (see SupplementalMethods). The
OXAGENAITDCaucasianFamilyCollection (762GDfemales,
123 GD males, 632 HT females, 85 HT males, 460 unaffected
female siblings, and 334 unaffectedmale siblings) were collected
from centers in the United Kingdom (Birmingham, Cambridge,
Glasgow, Oxford, and Sheffield), Denmark, and The Nether-
lands (12, 13) (see Supplemental Methods for further informa-
tion on recruitment criteria and geographical location of centers
contributing to these collections). Because AITD exhibits a
strong female preponderance, all month-of birth-data were split
by gender.
Data extraction and analysis
Month-by-month variation was screened using 2 or Fisher’s
exact tests, with odds ratios (ORs) and 95%confidence intervals
(CIs) calculated to determine the differences in birth rates for
each month between GD or HT cases and the UK general birth
rate (case-control collection) or unaffected siblings (family col-
lections). Data were also split by season of birth (Supplemental
Figures 1–3), and further 2/Fisher’s exact tests were performed.
To estimate within-year fluctuations for a 12-month periodicity
(simple harmonic seasonal variation), the Walter-Elwood test
for seasonality was used to determine the differences in the
month-of-birth distribution across all 12 months (P .05,Wal-
ter-Elwood test statistic 5.991 were significant).
Results
National UK Caucasian AITD Case Control
Collection
When comparing month-of-birth rates in GD females
from theNationalUKAITDCaucasianCaseControlCol-
lection against the general UK population, no significant
difference in birth rate across months, seasons, or fluctu-
ations across the whole 12-month period was detected
(Walter’s test statistic  2.71, P  .26) (Figure 1 and
Supplemental Figure 1). InGDmales, increasedbirth rates
in July (P  .03, OR 1.39, 95% CI 1.04–1.85) and re-
duced birth rates in September (P .01,OR0.59, 95%CI
0.39–0.90) and November (P  .03, OR 0.65, 95% CI
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0.42–0.98)were detected (Figure 1 and Supplemental Fig-
ure 1). Seasonal analysis supported the monthly analysis,
revealing lower birth rates in autumn for GD males (P 
.005,OR0.72 95%CI 0.57–0.91).When looking at birth
rates across the whole 12-month period, no significant
fluctuations were detected (Walter’s test statistic  4.10,
P  .13) (Figure 1).
WithinHT females, higher birth rates were seen in Jan-
uary (P  .009, OR 1.48, 95% CI 1.11–1.99) (Supple-
mental Figure 1); however, no seasonal differences or fluc-
tuations in birth rates across the 12-month period were
detected (Walter’s test statistic 0.92, P .63) (Figure 1
and Supplemental Figure 1). In HT males, a decreased
birth rate was seen in September (P .04, OR 0.24, 95%
CI 0.03–1.75); however, the 95% CI crossed OR 1.00,
suggesting caution when interpreting this result. Higher
birth rates were also detected in October (P  .02, OR
2.21, 95% CI 1.16–4.20) for HT males (Supplemental
Figure 1). This was not supported by seasonal analysis or
when looking at fluctuations across all 12 months in HT
males (Walter’s test statistic  3.78, P  .15) (Figure 1).
National UK Caucasian GD Family Collection and
OXAGEN AITD Caucasian Family Collection
A downside of using case-control collections to look at
month-of-birth effects is the difficulty ofmatching cases to
the general population. The advantage of looking within
families is that AITDpatients and their unaffected siblings
have been exposed to similar environments, reducing
the impact of nonshared environmental factors on
month-of-birth effects. As a complementary approach
to looking at month of birth within the National UK
Caucasian AITD Case Control Collection, month of
birth was also screened within two independent Cau-
casian AITD family collections.
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Figure 1. Month-of-birth distribution for National UK Caucasian AITD Case Control Collection. The National UK Caucasian AITD Case Control
Collection consisted of UK Caucasian GD and HT patients collected from specialist clinics across the United Kingdom in Birmingham,
Bournemouth, Cambridge, Cardiff, Exeter, Leeds, Sheffield, and Newcastle, which were compared against the UK general population live births
from 1956 through 1957 (see Supplemental Methods for details on recruitment criteria used for each collection). A, Female GD month of birth
compared against the general UK population month of birth. B, Male GD month of birth compared against the general UK population month of
birth. C, Female HT month of birth compared against the general UK population month of birth. D, Male HT month of birth compared against the
general UK population month of birth.
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When looking at month-of-birth effects within the Na-
tional UK Caucasian GD Family Collection female and
male GD cases compared against unaffected female and
male siblings, respectively, no variation in month, season,
or fluctuations across the whole 12-month period were
detected (Walter’s test statistic  3.35–3.80, P  .15–
0.19) (Figure 2 and Supplemental Figure 2). This did not
support the previously detected increase in autumn births
seen in GD males within the case-control collection.
Month-of-birth effects were also examined within the
OXAGEN AITD Caucasian Family Collection. When
looking at GD females and males compared with unaf-
fected females and male siblings, respectively, no signifi-
cant differences in month, season, or fluctuations across
the whole 12-month period were detected (Figure 2 and
Supplemental Figure 3). When looking at month-of-birth
fluctuations across all 12 months in HT females, greater
birth rates in winter/autumn and lower birth rates in
spring/summer relative to unaffected female siblings were
seen (Walter’s test statistic  7.47, P  .024) (Figure 2).
However,when looking atmonthly or seasonal effects, no
significant differences were detected, suggesting this was
not being driven by a given month or season but by vari-
ation across the whole period (Supplemental Figure 3). A
different picture emerged inHTmales,withmonthly anal-
ysis revealing a weak increase in birth rates for HT males
in January compared with unaffected males (P .04, OR
2.02, 95%CI 1.02–4.02) (Supplemental Figure 3). How-
ever, no variation in season or fluctuations across the
whole 12-month period were detected (Walter’s test sta-
tistic 1.75, P .42) (Figure 2 and Supplemental Figure
3).
When combining gender in each collection, no varia-
tion in month, season, or fluctuation across all 12 months
was detected inGDorHTacross all three collections (data
not shown).
Discussion
Screening month-of-birth effects in a large UK Caucasian
AITD Case Control Collection and two independent
AITDfamily collections, oneofUKCaucasiandescent and
one of European Caucasian descent, detected no consis-
tent association fora roleofmonthofbirthacross the three
collections. GD females, the largest AITD subgroup,
showed no month-of-birth effects in any of the three col-
lections. ForGDmales, somedifferences inmonth of birth
and reduction in GDmales born in autumn were detected
in the National UK Caucasian AITD Case Control Col-
lection. However, when looking at fluctuation across all
12 months, no change in birth rate distribution was seen.
No variation in month, season, or fluctuation across the
12-month period was seen in the two independent GD
family collections, suggesting that this decrease in GD
male birth rate in autumn within the case-control collec-
tion should be viewed with caution.
Some evidence for variation in monthly birth rates was
seen in HT males from the National UK Caucasian AITD
Case Control Collection and the OXAGEN AITD Cau-
casian Family Collection but could be due to the small
number ofHTmales in both collections (69 and 85males,
respectively). In HT females from the National UK Cau-
casian AITD Case Control Collection, a significant in-
crease in birth rates in January was detected; however, no
seasonal differences or fluctuations across the whole 12-
monthperiodwere found.Data from theOXAGENAITD
Caucasian Family Collection revealed fluctuation in birth
rates across the 12-month periodwithinHT females com-
pared with unaffected siblings. Birth rates across all au-
tumn/wintermonths, exceptDecember,werehigher inHT
females relative to unaffected female siblings in whom the
birth rates peaked in May (spring) and August (summer).
Month-by-month analysis showed that variation was not
being driven by a specific month, suggesting subtle
changes across all 12months contributed to differences in
birth rates detected by theWalter-Elwood test. This could
suggest that in the OXAGEN AITD Caucasian Family
Collection, variation in month of birth could be playing a
role in female HT onset.
There are several potential reasons that we found
month of birth effects only for HT females in our
OXAGENAITDCaucasian Family Collection. Variation
in seasonal temperatures, infection rates, and improving
hygiene across years/decades presents challengeswhen as-
sessing the long-term impact of environmental factors on
AITD. The broad spectrum of symptoms used to diagnose
GD and HT may dilute out a subset of patients whose
pathology was associated with month of birth. When
looking at UK infection rates for viruses and bacteria
linked with AITD,Adenovirus shows peak infection rates
in winter/spring, whereas Yersinia and Paravirus B14
show a peak incidence in spring/summer in the United
Kingdom, whereas Cytomegalovirus, Epstein-Barr, and
Hepatitis C do not show seasonal variation (http://
www.hpa.org.uk) (14–16), suggesting these infections are
unlikely to contribute to autumn/winter month of birth
effects. The use of UK monthly birth rate data from 1956
through 1957 to represent the general UK population
birth rate could be impacting upon our results due to pos-
sible effects of polio, Asian flu and Bornholm disease
(causedbyCoxsackieB) epidemicsduring this time (http://
www.hpa.org.uk) (17) or by masking localized peaks of
infection present in the locations that contributed to our
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Figure 2. Month-of-birth distribution within the National UK Caucasian GD Family collection and OXAGEN AITD Caucasian Family Collection. The
National UK Caucasian GD Family collection consisted of UK Caucasian GD patients and their unaffected siblings recruited from specialist clinics
across the United Kingdom, including Birmingham, Bournemouth, Cambridge, Cardiff, Exeter, Leeds, Sheffield, and Newcastle. The OXAGEN AITD
Caucasian Family Collection consisted of Caucasian GD and HT patients and their unaffected siblings recruited from specialist clinics across the
United Kingdom, including Birmingham, Cambridge, Glasgow, Oxford, and Sheffield, Denmark, and The Netherlands (see Supplemental Methods
for further details on recruitment criteria and geographical location of samples within each collection). A, National UK Caucasian GD Family
collection female GD index cases month of birth compared against UA female siblings month of birth. B, National UK Caucasian GD Family
collection male GD index cases month of birth compared against UA male siblings month of birth. C, OXAGEN AITD Caucasian Family Collection
female GD month of birth compared against female UA siblings month of birth. D, OXAGEN AITD Caucasian Family Collection male GD month of
birth compared against male UA siblings month of birth. E, OXAGEN AITD Caucasian Family Collection female HT month of birth compared
against female UA siblings month of birth. F, OXAGEN AITD Caucasian Family Collection male HT month of birth compared against male UA
siblings month of birth. UA, unaffected.
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case-control collection. Although some of the OXAGEN
AITD Caucasian Family Collection and our other collec-
tions were recruited from the same geographical locations
in the United Kingdom, including Birmingham and Shef-
field (with no overlap in patients between collections), the
OXAGEN collection also contained patients recruited
from different geographical locations, including samples
from Cambridge, Glasgow, and Oxford in the United
Kingdom, Denmark, and TheNetherlands (Supplemental
Methods). It is also important to note that no correction
for multiple testing was applied, which could possibly ex-
plain associations within some collections.
There has been much debate over whether month-of-
birth effects are actually a surrogate marker for date of
conception/gestational effects. InT1D, rotavirus infection
and subsequent antibody development in the mother dur-
ing gestation has been linked with pancreatic damage in
the fetus (18). Antibodies generated against maternal vi-
ral/bacterial infection may be more likely to cross the pla-
centa and cause autoimmune attack against the develop-
ing fetus’ pancreas rather than the thyroid gland, possibly
explaining why we did not detect consistent month-of-
birth effects across our AITD collections. Vitamin D de-
ficiency, which affects the immune system development
during pregnancy (19, 20), is also more prevalent during
the autumn/winter months, suggesting month-of-birth ef-
fects could be a surrogate marker for this condition. Al-
though impossible to access environmental impact before
birth inAITDpatients, it is possible thatHT females in the
OXAGENAITDCaucasian FamilyCollection could have
encountered a specific combination of environmental trig-
gers during gestation or after birth in the autumn/winter
months that impacted upon the development of their im-
mune systems and predisposed them to AITD, whereas
HT females in the other collections did not.
In conclusion, this study shows that in our UK and
Northern European Caucasian GD collections, month or
season of birth is unlikely to be exerting a significant im-
pact on disease development. Although some month-of-
birth effects for HT females in one collection cannot cur-
rentlybe ruledout, furtherwork in largerCaucasianAITD
collections across Europe is required to confirm whether
month of birth plays any role in AITD.
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